magda assem

professor clinical pathology

 (email)

PROMOTER METHYLATION MIGHT SHIFT THE BALANCE OF gALECTIN-3&12 EXPRESSION IN DE NOVO AML PATIENTS

  • View
  • What links here
Citation:
Assem, M., R. E. El-Araby, A. A. Al-karmalawy, R. Nabil, M. A. M. Kamal, A. Belal, H. I. Ghamry, M. A. S. Abourehab, M. M. Ghoneim, M. Y. Alshahrani, et al., "PROMOTER METHYLATION MIGHT SHIFT THE BALANCE OF gALECTIN-3&12 EXPRESSION IN DE NOVO AML PATIENTS", FRONTIERS IN GENETICS, issue 10.3389, pp. 13, 2023.
Export
  • RTF
  • Tagged
  • XML
  • BibTex
  • Google Scholar
PreviewAttachmentSize
fgene-14-1122864_1.pdf1.78 MB
  • Publications
  • Bio
  • Classes
  • The Synonymous Isocitrate Dehydrogenase 1 315C>T SNP Confers an Adverse Prognosis in Egyptian Adult Patients with NPM1-/CEBPA-Ne
  • file:///C:/Users/gogo/Desktop/4259-Published%20Article%20Text-32685-2-10-20201106.pdf

Recent Publications

PROMOTER METHYLATION MIGHT SHIFT THE BALANCE OF gALECTIN-3&12 EXPRESSION IN DE NOVO AML PATIENTS
PTEN mutations prevalence in HER2-positive breast cancer patients
Relative expression and prognostic significance of forkhead box P3 in childhood B-cell acute lymphoblastic leukemia.
Expression profiling of some Acute Myeloid Leukemia - associated markers to assess their diagnostic / prognostic potential
Prognostic impact of Additional Chromosomal Abnormalities in Egyptian Chronic Myeloid Leukemia Patients
more

Login Powered by OpenScholar